Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

John Hamer - aVenture Research

John Hamer

AddedMar 31, 2024

UpdatedOct 15, 2026

John Hamer

John Hamer

Co-Founder, Dcvc Bio

John Hamer's Career

Dcvc Bio

Investment Firm

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Palo Alto, CA, US

Managing Partner

2018 – present · 8 yrs

Co-Founder

AbCellera Biologics

Public$889MVancouver, British Columbia, CA

Board Member· Board

Arete Therapeutics

Public$51.7MHayward, CA, US

Founder

CH4 Global

Series B$45MHenderson, NV, US

Board Member· Board

Monsanto Growth Ventures

Investment FirmSan Francisco, CA, US

Managing Director

2012 – 2018 · 5 yrs

Monsanto

$63BSt. Louis, MO, US

Vice President

2012 – 2018 · 5 yrs

Burrill & Company

Investment FirmSan Francisco, CA, US

Managing Director

2003 – 2012 · 9 yrs

People Similar to John Hamer

Vineet BafnaCo-Founder · Abterra Biosciences

Pavel PevznerCo-Founder · Abterra Biosciences

Kristina BurowBoard Member · AgTech Accelerator

Philip AustinCo-Founder · Anterra Capital

Natalie CastellanaCEO · Abterra Biosciences

Leadership at Dcvc Bio

Matt OckoCo-Founder

Kiersten SteadCo-Founder

Zachary BogueCo-Founder

Anna FokinaCo-Founder

Similar to Dcvc Bio

DCVCSan Francisco, CA, USest. 2010DCVCSan Francisco, CA, US · est. 2010

Deep tech venture capital firm deploying capital through thirteen funds into AI, energy, biology, quantum, and space companies.

Investment Firm124

Similar to Monsanto Growth Ventures

FMC VenturesPhiladelphia, PA, USest. 2019FMC VenturesPhiladelphia, PA, US · est. 2019

FMC Ventures: The venture capital division of FMC Corporation.

Investment Firm5

AgFunderSan Francisco, CA, USest. 2013AgFunderSan Francisco, CA, US · est. 2013

San Francisco-based Agfunder Inc. is an online venture capital firm investing in food and agriculture innovations.

Investment Firm46

MGVSan Francisco, CA, USest. 2017MGVSan Francisco, CA, US · est. 2017

MGV: An early-stage VC fund, providing strategic investments, mentorship, and sales support to startups globally.

Investment Firm40

S2G VenturesChicago, IL, USest. 2014S2G VenturesChicago, IL, US · est. 2014

S2G Ventures: A multi-stage venture fund innovating in food and agriculture for global betterment.

Investment Firm70

Recent news

AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded WarrantsStockTitan · 2026

AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability ProfileStockTitan · 2026

AbCellera Reports Q2 2026 Business ResultsStockTitan · 2026

Leadership at AbCellera Biologics

Carl HansenBoard Member

Véronique LecaultBoard Member

Kathleen LisaingoCo-Founder

Similar to AbCellera Biologics

Prellis BiologicsSan Francisco, CA, USImmune System, Tissue Printingest. 2016Prellis BiologicsSan Francisco, CA, US · est. 2016

Prellis Biologics: Innovating in holographic tissue printing and immune system applications.

Series C · $79.4M46

Leadership at Arete Therapeutics

James H. SabryCEO

Dan JanneyBoard Member

Similar to Arete Therapeutics

Aristea TherapeuticsSan Diego, CA, USDrugsest. 2018Aristea TherapeuticsSan Diego, CA, US · est. 2018

Aristea Therapeutics: Developing novel drugs for autoimmune and inflammatory diseases.

Series B · $117.6M75

ArmetheonMenlo Park, CA, USBiopharmaceuticalsest. 2011ArmetheonMenlo Park, CA, US · est. 2011

Armetheon, Inc.: A clinical-stage biopharmaceutical firm developing novel drugs for unmet needs.

Series B · $31.3M30

Artielle ImmunoTherapeuticsSan Mateo, CA, USDrug Developmentest. 2004Artielle ImmunoTherapeuticsSan Mateo, CA, US · est. 2004

Artielle ImmunoTherapeutics: A biotech firm innovating drugs for autoimmune diseases treatment.

Series A · $11.2M8

Areteia TherapeuticsShort Hills, NJ, USAsthma Treatmentsest. 2022Areteia TherapeuticsShort Hills, NJ, US · est. 2022

Areteia Therapeutics: A biotech firm focused on improving asthma control through innovative treatments.

Series A · $350M30

Recent news

CH4 Global Opens the Worlds First Commercial-Scale Asparagopsis Production FacilityDCVC · 2025

Brief: CH4 Global signs offtake deal with CirPro to slash enteric methane with seaweed supplementsAgFunderNews · 2024

CH4 Global Signs First Offtake Agreement to Export Reduced-Methane BeefCH4 Global · 2024

Leadership at CH4 Global

Steve MellerCo-Founder

Nick GerritsenCo-Founder

Guy RoyalCo-Founder

Similar to CH4 Global

SymbrosiaKailua-Kona, HI, USLivestock Feedest. 2018SymbrosiaKailua-Kona, HI, US · est. 2018

Startup harnessing seaweed power to reduce livestock methane emissions.

Leadership at Monsanto

Hugh GrantBoard Member

John Francis QueenyFounder

Luke KissamAssociate General Counsel

Similar to Monsanto

SyngentaBasel, Basel-Stadt, CHCrop Protection, Seedsest. 2000SyngentaBasel, Basel-Stadt, CH · est. 2000

Syngenta, a Swiss agri-tech giant, empowers farmers globally with innovative solutions for sustainable, high-yield crop production.

Syngenta GroupBasel, Basel-Stadt, CHPesticides, Seedsest. 2020Syngenta GroupBasel, Basel-Stadt, CH · est. 2020

Syngenta AG, a ChemChina enterprise, provides advanced agricultural science, seeds, and pesticides.

FMCPhiladelphia, PA, USCrop Protection, Plant Healthest. 1883FMCPhiladelphia, PA, US · est. 1883

Established in 1883, FMC Corp is a US chemical manufacturer serving agriculture, textiles, and healthcare.

CortevaIndianapolis, IN, USCrop Protection, Seedest. 2019CortevaIndianapolis, IN, US · est. 2019

Corteva Agriscience, an American agriculture company, innovatively delivers solutions for global agriculture challenges, maximizing farmer productivity.

Leadership at Burrill & Company

Greg YoungBoard Member

G. Steven BurrillFounder

Frederick FrankBoard Member

Nicola A Campbell PhDBoard Member

Paul TirjanBoard Member

Similar to Burrill & Company

Burrage Capital ManagementBoston, MA, USest. 2011Burrage Capital ManagementBoston, MA, US · est. 2011

Health care-focused equity fund specializing in long-short strategies.

Investment Firm1

Bioluminescence VenturesSan Francisco, CA, US

est. 2022

Bioluminescence VenturesSan Francisco, CA, US · est. 2022

US-based Bioluminescence, a biotech venture firm, invests in transformative science for next-gen medicines, focusing on breakthrough biology, drug discovery, and computational platforms.

Investment Firm7

DCMMenlo Park, CA, USest. 1996DCMMenlo Park, CA, US · est. 1996

California-based financial services firm, DCM Ventures, partners with entrepreneurs to build impactful global tech companies.

Investment Firm275

DhvcPalo Alto, CA, USest. 2013DhvcPalo Alto, CA, US · est. 2013

DHVC: A Palo Alto-based venture capital firm investing in Enterprise, Consumer, FinTech, and Healthcare sectors.

Investment Firm19

Co-Founder

OmniAbEmeryville, CA, USAntibody Discoveryest. 2021

OmniAbEmeryville, CA, US · est. 2021

OmniAb: Your pharmaceutical partner in discovering next-generation therapeutics through diverse antibody repertoires.

Public · $70M175

AdimabLebanon, NH, USTherapeutic Antibodiesest. 2007AdimabLebanon, NH, US · est. 2007

Adimab, LLC is a biotechnology company that provides a yeast-based antibody discovery and engineering platform for biopharma partners.

Public · $45.5M149

Triveni BioWatertown, MA, USAntibodies, Therapeuticsest. 2023Triveni BioWatertown, MA, US · est. 2023

Triveni Bio develops first-in-class antibody therapeutics for immunological and inflammatory disorders using a genetics-informed approach.

Series C · $272M6

Rumin8

Rumin8

Rumin8 is a climate tech company developing cost-effective feed additives that cut livestock methane emissions.

Dsm-FirmenichDsm-Firmenich

dsm-firmenich is a nutrition and health company selling Bovaer methane-reducing cattle feed additive.

Alga BiosciencesSan Francisco, CA, USFeed Additivesest. 2021Alga BiosciencesSan Francisco, CA, US · est. 2021

Alga Biosciences: Cutting cattle methane with algae-based feed additives.

Bloom Burton & Co.Toronto, Ontario, CA

est. 2008

Bloom Burton & Co.Toronto, Ontario, CA · est. 2008

Bloom Burton & Co.: A specialized health sector investment banking firm.

Investment Firm33

Burleson + CompanyPetaluma, CA, USest. 2004Burleson + CompanyPetaluma, CA, US · est. 2004

Burleson + Co: SF-based investment management and venture capital firm serving high-net-worth entities.

Investment Firm5

Bunker Hill CapitalBoston, MA, USest. 2003Bunker Hill CapitalBoston, MA, US · est. 2003

Bunker Hill Capital: A US-based private equity firm offering strategic investment and financial services.

Investment Firm30